Concise and protective group-free syntheses of (±)-hamigeran B and (±)-4-bromohamigeran B

Organic Letters

Volumn 13, Issue 2, 2011, Pages 347-349

  Lau, Stephen Y W ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b EXELIXIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BROMOHAMIGERAN B; 4-BROMOHAMIGERAN B; HAMIGERAN B; NAPHTHOQUINONE;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION; SPONGE (PORIFERA); STEREOISOMERISM; SYNTHESIS;

ANIMALS; CYCLIZATION; MOLECULAR STRUCTURE; NAPHTHOQUINONES; PORIFERA; STEREOISOMERISM;

EID: 78651486697     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol102780s     Document Type: Article

References (34)

1. Wellington, K. D.; Cambie, R. C.; Rutledge, P. S.; Bergquist, P. R. J. Nat. Prod. 2000, 63, 79
2. Nicolaou, K. C.; Gray, D.; Tae, J. Angew. Chem., Int. Ed. 2001, 40, 3675
3. Nicolaou, K. C.; Gray, D.; Tae, J. Angew. Chem., Int. Ed. 2001, 40, 3679
4. Nicolaou, K. C.; Gray, D. L. F.; Tae, J. J. Am. Chem. Soc. 2004, 126, 613
5. Clive, D. L. J.; Wang, J. Angew. Chem., Int. Ed. 2003, 42, 3406
6. Clive, D. L. J.; Wang, J. Tetrahedon Lett. 2003, 44, 7731
7. Clive, D. L. J.; Wang, J. J. Org. Chem. 2004, 69, 2773
8. For a review of pre-2005 syntheses, see: Clive, D. L. J.; Wang, J. Org. Prep. Proc. Int. 2005, 37, 1
9. Trost, B. M.; Pissot-Soldermann, C.; Chen, I.; Schroeder, G. M. J. Am. Chem. Soc. 2004, 126, 4480
10. Trost, B. M.; Pissot-Soldermann, C.; Chen, I. Chem.-Eur. J. 2005, 11, 951
11. Taber, D. F.; Tain, W. J. Org. Chem. 2008, 73, 7560
12. Miesch, L.; Welsch, T.; Rietsch, V.; Miesch, M. Chem.-Eur. J. 2009, 15, 4394
13. For approaches to hamigeran B, see
14. Mehta, G.; Shinde, H. M. Tetrahedron Lett. 2003, 44, 7049
15. Cai, Z.; Harmata, M. Org. Lett. 2010, 12, 5668
16. Piers, E.; Cook, K. L.; Rogers, C. Tetrahedron Lett. 1994, 35, 8573
17. Enone 5 had been previously reported as a minor byproduct: Attah-Poku, S. K.; Chau, F.; Yadav, V. K.; Fallis, A. G. J. Org. Chem. 1985, 50, 3418
18. Snider, B. B.; Rodini, D. J.; van Straten, J. J. Am. Chem. Soc. 1980, 102, 5872
19. Corey, E. J.; Engler, T. A. Tetrahedron Lett. 1984, 25, 149
20. Devanathan, V. C.; Bhagan, V. U.; Arumugam, N. Indian J. Chem. 1983, 22B, 766
21. Ando, M.; Wada, T.; Kusaka, H.; Takase, K.; Hirata, N.; Yanagi, Y. J. Org. Chem. 1987, 52, 4792
22. For a similar application, see: Paquette, L. A.; Wang, X. J. Org. Chem. 1994, 59, 2052
23. Patel, K. M.; Reusch, W. Synth. Commun. 1975, 5, 27 For a modification, see: Paquette, L. A.; Wang, T.-Z.; Vo, N. H. J. Am. Chem. Soc. 1993, 115, 1676
24. Each of the intermediates 10 and 12 were used in the following transformation without purification and were not fully characterized. All other compounds were isolated, purified, and exhibited spectra in accord with assigned structures and gave satifactory elemental analyses or molecular mass determinations.
25. For reviews, see
26. Adlington, R. M.; Barrett, A. G. M. Acc. Chem. Res. 1983, 16, 55
27. Shapiro, R. H. Org. React. 1986, 23, 405
28. Konopelski, J. P.; Boehler, M. A. J. Am. Chem. Soc. 1989, 111, 4515
29. Boehler, M. A.; Konopelski, J. P. Tetrahedron 1991, 47, 4519
30. 1H NMR. As the stereochemistry of the newly formed stereogenic centers of 16 were to be destroyed through subsequent aromatization, no attempt was made to determine their configuration.
31. Note that the use of the acetal functionality in 13 was to both activate the diene and to provide the enol functionality in the cyclized product. Consequently, the ketal formed in 16 as a result of the Diels-Alder cyclization does not actually serve as a protective group.
32. For a review, see: Walker, D.; Hiebert, J. D. Chem. Rev. 1967, 67, 153
33. For a review, see: Rabjohn, N. Org. React. 1976, 24, 261
34. Fujisaki, S.; Eguchi, H.; Omura, A.; Okamoto, A.; Nishida, A. Bull. Chem. Soc. Jpn. 1993, 66, 1576